Silence Therapeutics Announces AGM Notice
Ticker: SLNCF · Form: 6-K · Filed: Apr 15, 2024 · CIK: 1479615
| Field | Detail |
|---|---|
| Company | Silence Therapeutics PLC (SLNCF) |
| Form Type | 6-K |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, corporate-governance, filing
TL;DR
Silence Therapeutics dropped its AGM notice, shareholders should check the website for details.
AI Summary
Silence Therapeutics plc announced its Notice of Annual General Meeting (AGM) on April 15, 2024, which was published on the company's website. The AGM is scheduled to take place, though specific details like date and time are not provided in this filing. The company is incorporated in the United Kingdom and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates that Silence Therapeutics is proceeding with its corporate governance activities, including the Annual General Meeting, which is a routine but important step for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing an upcoming Annual General Meeting, with no new financial or operational information that would typically increase risk.
Key Players & Entities
- Silence Therapeutics plc (company) — Registrant
- April 15, 2024 (date) — Date of Notice Publication
- https://www.silence-therapeutics.com (url) — Company Website for Notice
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report the publication of Silence Therapeutics plc's Notice of Annual General Meeting (AGM) on its website on April 15, 2024.
When was the Notice of Annual General Meeting published?
The Notice of Annual General Meeting was published on April 15, 2024.
Where can shareholders find the Notice of Annual General Meeting?
Shareholders can find the Notice of Annual General Meeting on the Silence Therapeutics plc website at https://www.silence-therapeutics.com.
What is the company's primary business sector?
Silence Therapeutics plc operates in the Pharmaceutical Preparations sector, with SIC code 2834.
Is Silence Therapeutics plc required to file Form 20-F or 40-F annually?
Yes, Silence Therapeutics plc is required to file annual reports under cover of Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 399 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-04-15 07:00:49
Filing Documents
- d818049d6k.htm (6-K) — 11KB
- d818049dex991.htm (EX-99.1) — 94KB
- d818049dex992.htm (EX-99.2) — 5KB
- g818049g0412024523540.jpg (GRAPHIC) — 3KB
- g818049g12a01.jpg (GRAPHIC) — 129KB
- g818049g12a02.jpg (GRAPHIC) — 82KB
- 0001193125-24-095485.txt ( ) — 408KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 15, 2024 SILENCE THERAPEUTICS PLC By: /s/ Craig Tooman Name: Craig Tooman Title: President and Chief Executive Officer